Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention

European Journal of Preventive Cardiology

Volumn 15, Issue 2, 2008, Pages 203-209

  Pedersen, Susanne S ^a,b   Denollet, Johan ^a   Van Gestel, Yvette R B M ^b   Serruys, Patrick W ^b   Van Domburg, Ron T ^b  

^a TILBURG UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

anxiety; depressive symptoms; percutaneous coronary intervention; type D personality

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL;

ADULT; ADVERSE OUTCOME; ANXIETY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERSONALITY; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SOCIAL PSYCHOLOGY; STABLE ANGINA PECTORIS; SYMPTOM; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANXIETY; CLUSTER ANALYSIS; CORONARY ARTERY DISEASE; DEPRESSION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PERSONALITY; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 41949133283     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3282f19d2f     Document Type: Article

References (42)

1. Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation 2005; 111: 250–253.
2. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21: 30–38.
3. Rozanski A, Blumenthal JA, Davidson KW, Saab PG, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45: 637–651.
4. Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000; 160: 1354–1360.
5. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66: 802–813.
6. Van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, et al Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814–822.
7. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–2774.
8. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF etal; for the cardiovascular outcomes research consortium. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003; 42: 1811–1817.
9. Dimatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression in patient adherence. Arch Intern Med 2000; 160: 2101–2107.
10. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, et al Relationship of depression to increased risk of mortality and re hospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161: 1849–1856.
11. Parashar S, Rumsfeld JS, Spertus JA, Reid KJ, Wenger NK, Krumholz HM, et al Time course of depression and outcome of myocardial infarction. Arch Intern Med 2006; 166: 2035–2043.
12. Poston WS, Haddock CK, Conard MW, Jones P, Spertus J. Assessing depression in the cardiac patient. When is the appropriate time to assess depression in the patient undergoing coronary revascularization? Behav Modif 2003; 27: 26–36.
13. De Jonge P, Ormel J, van den Brink RHS, van Melle JP, Spijkerman TA, Kuijper A, et al Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006; 163: 138–144.
14. Doyle F, McGee H, De La Harpe D, Shelley E, Conroy R. The Hospital Anxiety and Depression Scale depression subscale, but not the Beck Depression Inventory-Fast Scale, identifies patients with acute coronary syndrome at elevated risk of 1-year mortality: Brief depression scale predicts mortality in acute coronary syndrome. J Psychosom Res 2006; 60: 461–467.
15. Martens EJ, Denollet J, Pedersen SS, Scherders M, Griez E, Widdershoven J, et al Relative lack of depressive cognitions in post-myocardial infarction depression. J Affect Dis 2006; 94: 231–237.
16. Schrader G, Cheok F, Hordacre AL, Guiver N. Predictors of depression three months after cardiac hospitalization. Psychosom Med 2004; 66: 514–520.
17. Ladwig KH, Lehmacher W, Roth R, Breithardt G, Budde T, Borggrefe M. Factors which provoke post-infarction depression: results from the Post-Infarction Late Potential study (PILP). J Psychosom Res 1992; 36: 723–729.
18. Pedersen SS, Ong ATL, Serruys PW, Erdman RAM, van Domburg RT. Type D personality and diabetes predict the onset of depressive symptoms in patients following percutaneous coronary intervention. Am Heart J 2006; 151: 367.e1–367.e6.
19. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ etal; Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106–3116.
20. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr etal; for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701–709.
21. Tulner D. Effects of antidepressant therapy and biological mechanisms in depression following myocardial infarction: results from the MIND-IT [abstract]. J Psychosom Res 2006; 61: MS49.
22. Krumholz HM, Peterson ED, Ayanian JZ, Chin MH, DeBusk RF, Goldman L, et al Report of the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease. Circulation 2005; 111: 3158–3166.
23. Denollet J, Strik JJ, Lousberg R, Honig A. Recognizing increased risk of depressive comorbidity after myocardial infarction: looking for 4 symptoms of anxiety-depression. Psychother Psychsom 2006; 75: 346–352.
24. Januzzi JL, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary disease. Arch Intern Med 2000; 160: 1913–1921.
25. Pedersen SS, Denollet J. Type-D personality, cardiac events, and impaired quality of life: a review. Eur J Cardiovasc Prevention Rehabil 2003; 10: 241–248.
26. Van Melle JP, de Jonge P, Ormel J, Crijns HJGM, van Veldhuisen DJ, Honig A etal; for the MIND-IT investigators. Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J 2005; 26: 2650–2656.
27. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005; 67: 89–97.
28. Spindler H, Pedersen SS, Serruys PW, Erdman RAM, van Domburg RT. Type D personality predicts chronic anxiety following percutaneous coronary intervention in the drug-eluting stent era. J Affect Disord 2007; 99: 173–179.
29. Pedersen SS, Denollet J. Is Type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. Curr Cardiol Rev 2006; 2: 205–213.
30. Denollet J, Pedersen SS, Ong ATL, Erdman RAM, Serruys PW, van Domburg RT. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J 2006; 27: 171–177.
31. Kudielka BM, von Kanel R, Gander ML, Fischer JE. The interrelationship of psychosocial risk factors for coronary artery disease in a working population: do we measure distinct or overlapping psychological concepts? Behav Med 2004; 30: 35–43.
32. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–370.
33. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27: 363–370.
34. Bjelland I, Dahl AA, Haug TT, Neckelman D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52: 69–77.
35. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997; 42: 17–42.
36. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, Nathan RE, et al History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003; 145: 493–499.
37. Havranek EP, Spertus JA, Masoudi FA, Jones PG, Rumsfeld JS. Predictors of onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol 2004; 44: 2333–2338.
38. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom 2004; 73: 344–352.
39. Schiffer AA, Pedersen SS, Widdershoven JW, Hendriks EH, Winter JB, Denollet J. Type D personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12: 341–346.
40. Pedersen SS, Denollet J, Spindler H, Ong ATL, Serruys PW, Erdman RAM, et al Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. J Psychosom Res 2006; 61: 783–789.
41. Nicholson A, Fuhrer R, Marmot M. Psychological distress as a predictor of CHD events in men: the effect of persistence and components of risk. Psychosom Med 2005; 67: 522–530.
42. Sirois BC, Sears SF Jr, Bertolet B. Biomedical and psychosocial predictors of anginal frequency in patients following angioplasty with and without coronary stenting. J Behav Med 2003; 26: 535–551.